arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Wednesday 21 September

Please find below the programme schedule for Wednesday 21 September 2022.

Print program

Wednesday 21 Sep

08:00

Conference hall B | General Assembly

09:30

Conference hall B | Presidential oration

Speaker: Dr. John Perfect, USA | Chair: Arunaloke Chakrabarti, India

10:30

Break

Conference hall C - Exhibition

Parallel session I

Parallel session I will take place from 11:00 AM - 12:30 PM and consists of five symposia.

Conference hall B | S1.1 Controversies in the clinical management of invasive candidiasis in critically ill patients

Chairs: Subhash Todi, India and Arnaldo Lopes Colombo, Brazil

11:00

S1.1a Gaps in the guidelines for the clinical management of candidemia

Arnaldo Lopes Colombo, Brazil

11:20

S1.1b Should we continue to use conventional doses of candins for all ICU patients?

Subhash Todi, India

11:40

S1.1c Intra-abdominal candidiasis: best clinical management and strategies to monitor response to therapy

Prakash Shastri, India

12:00

S1.1d* Risk Factors Associated with Oropharyngeal Candidiasis in COVID-19 Patients: A Case Control Study

Mohammadreza Salehi, Iran

12:15

Q&A with all speakers

Conference hall A | S1.2 S Animal Mycoses

Chairs: Vanessa Barrs, Hong Kong and Andrea Peano, Italy

11:00

S1.2a 'Veterinary relevant and zoonotic fungal groups'

Amir Seyedmousavi, USA

11:20

S1.2b Penicilliosis: an emerging concern in dogs?

Jacques Guillot, France

11:40

S1.2c Diagnosis of fungal infections in animals: combining the old and the new to maximize results

Andrea Peano, Italy

12:00

S1.2d* TBD

12:15

Q&A with all speakers

Suite No. 292 (Ruby) | S1.3 Malassezia: genetics, genomics, and biology

Chairs: Kaustuv Sanyal, India / Shivaprakash Rudramurthy, India

11:00

S1.3a Molecular taxonomy of Malassezia

Prasanna Honnavar, Antigua & Barbuda

11:20

S1.3b Chromosomal stability and speciation in the Malassezia Clade

Kaustuv Sanyal, India

11:40

S1.3c Diversity and hybridization in Malassezia furfur

Bart Theelen, Netherlands

12:00

S1.3d* The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation

Salomé LeibundGut-Landmann, Switzerland

12:15

Q&A with all speakers

Suite No. 293 (Sapphire) S1.4 Fungal infections in Asia, bringing it out of the dark

Chairs: Yee-Chun Chen, Taiwan and Ariya Chindamporn, Thailand

11:00

S1.4a Paradigm shift in the epidemiology of invasive fungal infections during COVID-19 pandemics

Atul Patel, India

11:20

S1.4b Challenges in diagnosing & management of invasive fungal infections during pandemic

Methee Chayakulkeeree, Thailand

11:40

S1.4c Antifungal stewardship & infection control

Pratibha Kale, India

12:00

S1.4d* Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing cryptococcosis

Alexandre Alanio, France

12:15

Q&A with all speakers

Suite No. 294 (Emerald) | S1.5 Mycotic Keratitis

Chairs: Savitri Sharma, India and Niranjan Nayak, India

11:00

S1.5a Epidemiology of myotic keratitis in developing countries

Phillip Thomas, India

11:20

S1.5b Epidemiology of mycotic keratitis in West Africa

Savitri Sharma, India

11:40

S1.5c Proteomics approach in the understanding of fungal keratitis

Lalitha Prajna, India

12:00

S1.5d* Spectrum of Aetiological agents of Mycotic keratitis: A 11 year review

Phillip Thomas, India

12:15

Q&A with all speakers

12:30

Lunch and Poster session 1

Conference hall C - Exhibition

Conference hall B | Sponsored symposium 1: Pragmatic approach in management of invasive mold infection (IMI)

This symposium is sponsored by Gilead

12:30

Welcome

Dr. Arunaloke Chakrabarti

12:35

Current trends in epidemiology and resistance

Dr. Arunaloke Chakrabarti

12:45

What are the challenges and approaches in IMI diagnoses?

Dr. Martin Honigl

13:15

Why empirical therapy in management of IMI in hematological patients?

Dr. Johan Maertens

13:45

Q&A

With all speakers

13:55

Close

Dr. Arunaloke Chakrabarti

14:00

Conference hall B | Keynote (P1): Recent Developments of the ECMM-ISHAM-ASM Global Guideline Program

Oliver Cornely, Germany

Parallel session 2

Parallel session 2 will take place from 03:00 - 04:30 PM and consists of five symposia.

Conference hall B | S2.1 Update on Mucormycosis

Chairs: Atul Patel, India and Arunaloke Chakrabarti, India

15:00

S2.1a Mucormycosis in Developing/Asian country

Atul Patel, India

15:20

S2.1b Update in pathogenesis and diagnosis of mucormycosis

Ashraf Ibrahim, USA

15:40

S2.1c Global guideline in management

Oliver Cornely, Germany

16:00

S2.1d* Incidence of mixed fungal infections in Post-Covid-19 outbreak of Mucormycosis

Subhashree Mohapatra, India

16:15

Q&A with all speakers

Conference hall A | S2.2 Histoplasmosis & Talaromycosis

Chairs: David Denning, UK and Malini Capoor, India

15:00

S2.2a African histoplasmosis

Rita Oladele, Nigeria

15:20

S2.2b Challenges in Latin America

Beatriz Gomez, Colombia

15:40

S2.2c Talaromycosis in HIV-negative Patients: Challenges and Countermeasures

Methee Chayakulkeeree, Thailand

16:00

S2.2d* Evaluation of new tools for the diagnosis of histoplasmosis

Aude Sturny Leclere, France

16:15

Q&A with all speakers

Suite No. 292 (Ruby) | S2.3 Novel Diagnostic tools for Invasive Mold infection

Chairs: Cornelia Lass Flörl, Austria and Martin Hoenigl, Austria

15:00

S2.3a Lateral Flow Device Tests for Diagnosis of Invasive Aspergillosis: What is their role in 2021?

Katrien Lagrou, Belgium

15:20

S2.3b How can Cytokines be used for Diagnosis and Treatment Monitoring of Invasive Mold Infections?

Juergen Prattes, Austria

15:40

S2.3c High Resolution Digital DNA Melting: a breakthrough in diagnosing IMI?

Tyler Goshia, USA

16:00

S2.3d* Mixed biofilm of Aspergillus fumigatus and Stenotrophomonas maltophilia: microscopic visualization of galactosaminogalactan and galactomannan polysaccharides in the extracellular matrix

Françoise Botterel, France

16:15

Q&A with all speakers

Suite No. 293 (Sapphire) | S2.4 Veterinary Mycology Research

Chairs: Jacques Guillot, France and Amir Seyedmousavi, USA

15:00

S2.4a Pythiosis: an emerging disease in Hong Kong

Vanessa Barrs, Hong Kong

15:20

S2.4b Population biology of hedgehog fungus Trichophyton eninacei

Vit Hubka, Czech Republic

15:40

S2.4c Metagenomic analysis of histoplasmosis in dogs

Gregory Jouvion, France

16:00

S2.4d* TBD

16:15

Q&A with all speakers

Suite No. 294 (Emerald) | S2.5 Rare Yeasts

Chair: Peter-Michael Rath, Germany

15:00

S2.5a Magnsiomyces spp.

Axel Hamprecht, Germany

15:20

S2.5b Trichosporon spp.

João Nobrega de Almeida, Brazil

15:40

S2.5c Exophiala spp.

Joerg Steinmann, Germany

16:00

S2.5d* Exploring multidrug resistance, fitness compensation and collateral sensitivity in Candida auris: fight fire with fire?

Hans Carolus, Belgium

16:15

Q&A with all speakers

16:30

Break

Conference hall C - Exhibition

Parallel session 3

Parallel session 3 will take place from 16:45 hrs. until 18:15 hrs. and consists of five symposia.

Conference hall B | S3.1 Neglected implantation mycoses

Chairs: Flavio Queiroz-Telles, Brazil and Alexandro Bonifaz, Mexico

16:45

S3.1a Update in mycetoma control

Ahmed Hassan Fahal, Sudan

17:05

S3.1b Chromoblastomycosis elimination S3.1b Chromoblastomycosis elimination

Daniel Wagner, Brazil

17:25

S3.1c Why sporotrichosis and Paracoccidioidomycosis should be considered neglected tropical disease?

Flavio Queiroz-Telles, Brazil

17:45

S3.1d* High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina

Guillermo Garcia Effron, Argentina

18:00

Q&A with all speakers

Conference hall A | S3.2 Challenging clinical cases

16:45

For more information about the speakers and panellist member please read more

Speakers:
Rajeev Soman, India
Tanu Singhal, India
Atul Patel, India
Ram Gopalakrishnan, India

16:45-17:30 hrs.
Panellists:
Camilla Rodrigues, India
Subhash Todi, India
John Perfect, USA
Jacques Meis, Netherlands

17.30-18.15
Panellists:
Arunaloke Chakrabarti, India
Ayesha Sunavala, India
Oliver Cornely, Germany
Cornelia Lass-Flörl, Austria

Suite No. 292 (Ruby) | S3.3 Innate immune responses to pathogenic fungi

Chair: Jatin Vyas, USA

16:45

S3.3a Lessons from the clinic: neutrophil heterogeneity in response to Candida

Michael Mansour, USA

17:05

S3.3b role of type i interferons in the host defense against pathogenic fungi

Jatin Vyas, USA

17:25

S3.3c Alveolar Macrophage mediated host resistance against Aspergillus fumigatus

Joshua Obar, USA

17:45

S3.3d* Influenza- versus COVID-19-associated pulmonary aspergillosis: profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples

Simon Feys, Belgium

18:00

Q&A with all speakers

Suite No. 293 (Sapphire) | S3.4 Free oral paper session

Chairs: Shukla Das, India and Nandini Sethuraman, India

16:45

S3.4a* The repurposing approach identifies pitavastatin (calcium) making fluconazole fungicidal by inhibiting ergosterol synthesis

Wanqian Li, China

17:05

S3.4b* Lactoferrin, a natural source of peptides that potentiate the antifungal activity of amphotericin B

Dee Carter, Australia

17:25

S3.4c* A pipeline towards the identification of novel antifungal compounds derived from the microbial dark matter

Giel Vanreppelen, Belgium

17:45

S3.4d* The Role of NLRP3 Inflammasome in Host Defense during Talaromyces marneffei Infection

Sha Lu, China

18:00

S3.4e* Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence

Chinmayee Awasthy, Belgium

Suite No. 294 (Emerald) | S3.5 Environmental Exposure - Risk for Human Fungal Disease

Chairs: Esther Segal, Israel and Malcolm Richardson, UK

16:45

S3.5a Fungal contamination in sand and water of sea, lakes and river beaches: risk factor for fungal human disease

Esther Segal, Israel

17:05

S3.5b Environment as source of fungal infections: new tools and new concepts

Jean-Pierre Gangneux, France

17:25

S3.5c Animals and soil as source of fungal contamination and exposure acting as risk factor for human fungal infection

Mihai Mares, Romania

17:45

S3.5d* Identification of fungicidal activity of otilonium bromide by the repurposing approach

Cheng Zhen, China

18:00

Q&A with all speakers

18:15

Conference hall B | Key note (P2): Evolution of mating systems and genome organization in budding yeasts

Ken Wolfe, Ireland